135 related articles for article (PubMed ID: 34740503)
1. Reply to Sanjay B. Kulkarni, Pankaj M. Joshi, Marco Bandini, et al.'s Letter to the Editor re: Sanad Saad, Nadir I. Osman, Christopher R. Chapple. Female Urethra: Is Ventral the True Dorsal? Eur Urol 2020;78:e218-9.
Saad S; Osman NI; Chapple CR
Eur Urol; 2022 Jan; 81(1):e16-e17. PubMed ID: 34740503
[No Abstract] [Full Text] [Related]
2. Re: Sanad Saad, Nadir I. Osman, Christopher R. Chapple. Female Urethra: Is Ventral the True Dorsal? Eur Urol 2020;78:e218-9.
Kulkarni SB; Joshi PM; Bandini M; Morey AF; Santucci RA; Fisch M; Djinovic R; Montorsi F; Barbagli G; Mundy T
Eur Urol; 2022 Jan; 81(1):e14-e15. PubMed ID: 34756627
[No Abstract] [Full Text] [Related]
3. Re: Helena Vila-Reyes, G. Joel DeCastro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36.
Panebianco V; Del Giudice F; Narumi Y; Simone G; De Berardinis E; Catto JWF
Eur Urol; 2021 Feb; 79(2):e52-e53. PubMed ID: 33261940
[No Abstract] [Full Text] [Related]
4. Reply to Valeria Panebianco, Francesco Del Giudice, Yoshifumi Narumi, Giuseppe Simone, Ettore De Berardinis, and James Catto's Letter to the Editor re: Helena Vila-Reyes, G. Joel De Castro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36.
Vila-Reyes H; Joel DeCastro G; McKiernan JM
Eur Urol; 2021 Feb; 79(2):e54-e55. PubMed ID: 33248798
[No Abstract] [Full Text] [Related]
5. Reply to Yunjin Bai, Yubo Yang, Yin Tang's Letter to the Editor, re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01, Study. Eur Urol 2020;77:636-43.
Bandini M; Necchi A
Eur Urol; 2020 Jun; 77(6):e159-e160. PubMed ID: 32184002
[No Abstract] [Full Text] [Related]
6. Re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020;77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer?
Vila-Reyes H; DeCastro GJ; McKiernan JM
Eur Urol; 2021 Jan; 79(1):e35-e36. PubMed ID: 32829975
[No Abstract] [Full Text] [Related]
7. Reply to Nadir I. Osman, Christopher R. Chapple, Sheila MacNeil's Letter to the Editor re: Guido Barbagli, Massimo Lazzeri. Clinical Experience with Urethral Reconstruction Using Tissue-engineered Oral Mucosa: A Quiet Revolution. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.043.
Barbagli G; Lazzeri M
Eur Urol; 2015 Nov; 68(5):e101-2. PubMed ID: 26260002
[No Abstract] [Full Text] [Related]
8. Re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020;77:636-43.
Bai Y; Yang Y; Tang Y
Eur Urol; 2020 Jun; 77(6):e158. PubMed ID: 32199681
[No Abstract] [Full Text] [Related]
9. Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Francesco Soria, Marco Moschini, David D'Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus 2020;6:1233-9.
Soria F; D'Andrea D; Gontero P; Shariat SF
Eur Urol Focus; 2022 Mar; 8(2):633-634. PubMed ID: 33875390
[No Abstract] [Full Text] [Related]
10. Reply to Bernhard Liedl, Klaus Goeschen, and Florian Wagenlehner's Letter to the Editor re: Benoit Peyronnet, Emma Mironska, Christopher Chapple, et al. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol 2019, 75:988-1000.
Peyronnet B; Chapple C; Cornu JN
Eur Urol; 2019 Oct; 76(4):e107-e108. PubMed ID: 31326217
[No Abstract] [Full Text] [Related]
11. Reply to Santhanam Sundar and Paul Symonds' Letter to the Editor re: Syed A. Hussain, Nuria Porta, Emma Hall, et al. Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial. Eur Urol 2021;79:307-15.
Hussain SA; Porta N; Hall E; Qureshi M; Lewis R; Huddart R; James ND
Eur Urol; 2021 Aug; 80(2):e51-e52. PubMed ID: 34053780
[No Abstract] [Full Text] [Related]
12. Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55-65: Assessing the Morbidity of Multimodal Approaches in Patients with Muscle-invasive Bladder Cancer.
Vetterlein MW; Gild P; Fisch M; Rink M
Eur Urol; 2020 Aug; 78(2):e77-e78. PubMed ID: 32376138
[No Abstract] [Full Text] [Related]
13. Reply to Wael Agur and Jawad Freites' Letter to the Editor re: Ferdinando Fusco, Mohamed Abdel-Fattah, Christopher R. Chapple, et al. Updated Systematic Review and Meta-analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence. Eur Urol 2017;72:567-91.
Fusco F; Novara G
Eur Urol; 2018 Mar; 73(3):e56-e57. PubMed ID: 28967555
[No Abstract] [Full Text] [Related]
14. Reply to So-Ryoung Lee, Byoung-Won Park, and Jae Heon Kim's Letter to the Editor re: Christian Gratzke, Rob van Maanen, Christopher Chapple, et al. Long-term Safety and Efficacy of Combined Mirabegron and Solifenacin Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II). Eur Urol 2018;74:501-9.
Gratzke C; Siddiqui E
Eur Urol; 2019 Mar; 75(3):e59-e60. PubMed ID: 30773205
[No Abstract] [Full Text] [Related]
15. Reply to Jeremy Y.C. Teoh, Thomas R.W. Herrmann, and Marek Babjuk's Letter to the Editor re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting and Data System). Eur Urol 2018;74:294-306.
Panebianco V; Barentsz J; Narumi Y; Catto JWF
Eur Urol; 2019 Feb; 75(2):e29-e30. PubMed ID: 30471881
[No Abstract] [Full Text] [Related]
16. Reply to Francesco Montorsi, Marco Bandini, Alberto Briganti, et al. Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations. Eur Urol 2020;78:489-91: Can Open and Robotic Radical Cystectomy be Considered Equally Effective in 2020?
Witjes JA; Ribal MJ; van der Heijden AG
Eur Urol; 2020 Oct; 78(4):492-493. PubMed ID: 32693931
[No Abstract] [Full Text] [Related]
17. Reply to Andrea Necchi, Antonella Messina, and Alberto Briganti's Letter to the Editor re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting and Data System). Eur Urol 2018;74:294-306.
Panebianco V; Barentsz J; Narumi Y; Catto J;
Eur Urol; 2018 Nov; 74(5):e109. PubMed ID: 30029821
[No Abstract] [Full Text] [Related]
18. Reply to Jonathan Aning, Paul McCoubrie, and Jon Oxley's Letter to the Editor re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41.
Gandaglia G; Montorsi F; Briganti A
Eur Urol; 2020 Nov; 78(5):e200. PubMed ID: 32800726
[No Abstract] [Full Text] [Related]
19. Reply to Marco Bandini, Andrea Salonia, and Francesco Montorsi's Letter to the Editor re: Laura Elst, Manon T.A. Vreeburg, Hielke Martijn de Vries, et al. Corporal Skip Metastases in Penile Squamous Cell Carcinoma: An Unknown and Distinct Pattern of Spread with Poor Prognosis. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.005.
Elst L; Vreeburg MTA; Brouwer OR; Albersen M
Eur Urol Oncol; 2024 Mar; ():. PubMed ID: 38493073
[No Abstract] [Full Text] [Related]
20. Reply to Nicholas G. Zaorsky, Daniel E. Spratt, and Pierre Blanchard's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319-28.
Moschini M; Zaffuto E; Mattei A; Karakiewicz PI; Shariat SF
Eur Urol; 2019 Apr; 75(4):e98-e99. PubMed ID: 30503180
[No Abstract] [Full Text] [Related]
[Next] [New Search]
